Literature DB >> 19738216

Progress on incorporating the patient perspective in outcome assessment in rheumatology and the emergence of life impact measures at OMERACT 9.

John R Kirwan1, Stanton Newman, Peter S Tugwell, George A Wells, Sarah Hewlett, Leanne Idzera, Britta Laslo, Lyn M March, Patricia Minnock, Pam Montie, Jo Nicklin, Tamara Rader, Pamela Richards, Tessa C Sanderson, Maria Suarez-Almazor, Elizabeth Tanjong-Ghogomu, Erin Ueffing, Vivian Welch.   

Abstract

The Patient Perspective Workshop included over 100 researchers and 18 patient participants from 8 countries. Following preconference reading and short plenary presentations, breakout groups considered work undertaken on measurement of sleep, assessing interventions to develop the effective consumer, and assessing psychological and educational interventions. The workshop explored the best way to identify other outcome domains (and instruments) that should be measured in observational or interventional studies with broader intentions than simply altering outcomes captured in the traditional "core set" plus fatigue. Four sleep questionnaires showed promise and will be the subject of further study. The Effective Consumer scale (EC-17) was reviewed and the concept Effective Consumer was well received. Participants thought it worthwhile to measure the skills and attributes of an effective consumer and develop an intervention that would include education in all of the scale's categories. Assessment of educational and psychological interventions requires a wider set of instruments than is currently used; these should relate to the purpose of the intervention. This principle was extended to include wider measures of the impact of disease on life, as indicated in the International Classification of Functioning, Disability and Health. Life impact measure sets covering domains appropriate to different rheumatic conditions and focused on different interventions might be defined by future OMERACT consensus. Measurement instruments within these domains that are valid for use in rheumatic conditions can then be identified and, in the case of psychological and educational interventions, chosen to fit with the purpose of the intervention.

Entities:  

Mesh:

Year:  2009        PMID: 19738216     DOI: 10.3899/jrheum.090360

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  12 in total

Review 1.  Treating Fatigue in Rheumatoid Arthritis: Does Patient Age Matter?

Authors:  Till Uhlig; Sella A Provan
Journal:  Drugs Aging       Date:  2018-10       Impact factor: 3.923

Review 2.  [Treat-to-target from the patient perspective].

Authors:  E Gromnica-Ihle; M Rink
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

Review 3.  Quality and acceptability of patient-reported outcome measures used in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review.

Authors:  Kirstie L Haywood; Sophie Staniszewska; Sarah Chapman
Journal:  Qual Life Res       Date:  2011-05-18       Impact factor: 4.147

Review 4.  Patient-reported outcomes and adult patients' disease experience in the idiopathic inflammatory myopathies. report from the OMERACT 11 Myositis Special Interest Group.

Authors:  Helene Alexanderson; Maria Del Grande; Clifton O Bingham; Ana-Maria Orbai; Catherine Sarver; Katherine Clegg-Smith; Ingrid E Lundberg; Yeong Wook Song; Lisa Christopher-Stine
Journal:  J Rheumatol       Date:  2014-01-15       Impact factor: 4.666

5.  "If i wasn't this robust": patients' expectations and experiences at the Outcome Measures in Rheumatology Conference 2010.

Authors:  Maarten P T de Wit; Marije S Koelewijn-van Loon; Sarah Collins; Tineke A Abma; John Kirwan
Journal:  Patient       Date:  2013       Impact factor: 3.883

6.  Do not forget the professional--the value of the FIRST model for guiding the structural involvement of patients in rheumatology research.

Authors:  Maarten P T de Wit; Janneke E Elberse; Jacqueline E W Broerse; Tineke A Abma
Journal:  Health Expect       Date:  2013-01-31       Impact factor: 3.377

7.  Patient and public engagement in health-related quality of life and patient-reported outcomes research: what is important and why should we care? Findings from the first ISOQOL patient engagement symposium.

Authors:  Kirstie Haywood; Jo Brett; Sam Salek; Nancy Marlett; Colin Penman; Svetlana Shklarov; Colleen Norris; Maria Jose Santana; Sophie Staniszewska
Journal:  Qual Life Res       Date:  2014-09-07       Impact factor: 4.147

8.  Emotions related to participation restrictions as experienced by patients with early rheumatoid arthritis: a qualitative interview study (the Swedish TIRA project).

Authors:  Gunnel Östlund; Mathilda Björk; Ingrid Thyberg; Mikael Thyberg; Eva Valtersson; Birgitta Stenström; Annette Sverker
Journal:  Clin Rheumatol       Date:  2014-05-17       Impact factor: 2.980

9.  Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment.

Authors:  Michael Schiff; Tsutomu Takeuchi; Roy Fleischmann; Carol L Gaich; Amy M DeLozier; Douglas Schlichting; Wen-Ling Kuo; Ji-Eon Won; Tara Carmack; Terence Rooney; Patrick Durez; Saeed Shaikh; Rodolfo Pardo Hidalgo; Ronald van Vollenhoven; Cristiano A F Zerbini
Journal:  Arthritis Res Ther       Date:  2017-09-18       Impact factor: 5.156

10.  Content validity of the Dutch Rheumatoid Arthritis Impact of Disease (RAID) score: results of focus group discussions in established rheumatoid arthritis patients and comparison with the International Classification of Functioning, Disability and Health core set for rheumatoid arthritis.

Authors:  Marieke M Ter Wee; Lilian H van Tuyl; Birgit S Blomjous; Willem F Lems; Maarten Boers; Caroline B Terwee
Journal:  Arthritis Res Ther       Date:  2016-01-22       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.